ADVM logo

Adverum Biotechnologies (ADVM)

Profile

Full Name

Adverum Biotechnologies, Inc.

Ticker Symbol

ADVM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 31, 2014

Indexes

Not included

Website

http://adverum.com

Employees

121

Key Details

Price

$3.46(+0.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.60M

Annual EPS

-$11.60(+25.64% YoY)

PE ratio

-

Next earnings date

Apr 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.46
ADVM price is $3.46

30-Day Relative Volume

0.87
ADVM 30-day relative volume is 0.87

Price Performance

Price Today change

+0.73%
ADVM price is up +0.73% today

Price YTD change

-26.02%
ADVM price is down -26.02% since January 1st

Price 1-year change

-70.55%
ADVM price is down -70.55% year-on-year

Price 3-year change

-71.21%
ADVM price is down -71.21% over the past 3 years

Price Range

Price All-time high

$624.80
ADVM price is currently -99.45% below its historical high of $624.80

Price 3-year low

$3.07
ADVM price is currently +12.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$71.87M
ADVM market capitalization is $71.87 million

Market cap 3-year change

-39.36%
ADVM market capitalization is down -39.36% over the past 3 years

Market cap All-time high

$2.06B
ADVM market capitalization is currently -96.51% below its historical high of $2.06 billion

Market cap sector rank

43.47%
ADVM market capitalization is higher than 43.47% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.23%
ADVM shares outstanding is up +0.23% year-on-year

Shares Outstanding 3-Year Change

+110.65%
ADVM shares outstanding is up +110.65% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
ADVM beta is 1.10

200-day SMA

$6.10
ADVM price is currently -43.36% below its 200-day simple moving average

50-day SMA

$4.36
ADVM price is currently -20.72% below its 50-day simple moving average

RSI

37.63
ADVM 14-day relative strength index is 37.63

Volume

0.87
ADVM 30-day relative volume is 0.87

ATR

$0.41
ADVM average true range is $0.41

10-day Historical Volatility

112.97%
ADVM 10-day historical volatility is 112.97%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.60M
ADVM annual revenue is $3.60 million

Revenue Analysts estimate

$1.00M
ADVM annual revenue is currently +260.00% higher than the consensus analysts' forecast

Revenue 1-year change

-
ADVM annual revenue 1-year change is unknown

Revenue Sector rank

19.93%
ADVM annual revenue is higher than 19.93% of companies in Healthcare sector

EPS

EPS

-$11.60
ADVM annual earnings per share is -$11.60

EPS Analysts estimate

-$5.04
ADVM annual earnings per share is currently +130.31% higher than the consensus analysts' forecast

EPS 1-year change

+25.64%
ADVM annual earnings per share is up +25.64% year-on-year

EPS Sector rank

10.49%
ADVM annual earnings per share is higher than 10.49% of companies in Healthcare sector

Profit

Gross profit

-
ADVM annual gross profit value is unknown

Gross margin

-
ADVM annual gross profit margin value is unknown

Operating profit

-$123.99M
ADVM annual operating income is -$123.99 million

Operating margin

-3444.19%
ADVM annual operating profit margin is -3444.19%

Net income

-$117.17M
ADVM annual net profit is -$117.17 million

Net margin

-3254.58%
ADVM annual net profit margin is -3254.58%

Expenses

Total expenses

$127.59M
ADVM annual total expenses is $127.59 million

Operating expenses

$127.59M
ADVM annual total operating expenses is $127.59 million

Cost of goods sold

-
ADVM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$49.91M
ADVM annual SGA is $49.91 million

Depreciation and amortization

$5.64M
ADVM annual depreciation & amortization is $5.64 million

Interest expense

-
ADVM annual interest expense value is unknown

Income tax

-$1.08M
ADVM annual income tax is -$1.08 million

EBIT & EBITDA

EBIT

-$123.99M
ADVM annual earnings before interest & taxes is -$123.99 million

EBITDA

-$118.35M
ADVM annual EBITDA is -$118.35 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$173.01M
ADVM annual total assets is $173.01 million

Non current assets

$70.24M
ADVM annual long term assets is $70.24 million

Current assets

$102.77M
ADVM annual total current assets is $102.77 million

Cash and cash equivalents

$75.00M
ADVM annual cash & cash equivalents is $75.00 million

Accounts receivable

-
ADVM annual accounts receivable value is unknown

Inventory

-
ADVM annual inventory value is unknown

Liabilities

Total liabilities

$89.54M
ADVM annual total liabilities is $89.54 million

Long term liabilities

$64.63M
ADVM annual total long term liabilities is $64.63 million

Current liabilities

$24.91M
ADVM annual total current liabilities is $24.91 million

Accounts payable

$1.92M
ADVM annual accounts payable is $1.92 million

Debt

Total debt

$75.04M
ADVM annual total debt is $75.04 million

Total debt 1-year change

-29.74%
ADVM annual total debt is down -29.74% year-on-year

Long term debt

$64.63M
ADVM annual long term debt is $64.63 million

Short term debt

$10.41M
ADVM annual short term debt is $10.41 million

Equity & Capital

Shareholders equity

$83.47M
ADVM annual stockholders equity is $83.47 million

Book value

$83.47M
ADVM annual book value is $83.47 million

Retained earnings

-$919.78M
ADVM annual retained earnings is -$919.78 million

Working capital

$77.86M
ADVM annual working capital is $77.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$90.90M
ADVM annual cash flow from operations is -$90.90 million

Cash from operations 1-year change

+15.9%
ADVM annual cash flow from operations is up +15.9% year-on-year

Cash from investing

$96.88M
ADVM annual cash flow from investing activities is $96.88 million

Cash from investing 1-year change

-31.64%
ADVM annual cash flow from investing activities is down -31.64% year-on-year

Cash from financing

$69.00K
ADVM annual cash flow from financing activities is $69.00 thousand

Cash from financing 1-year change

-88.63%
ADVM annual cash flow from financing activities is down -88.63% year-on-year

CAPEX

CAPEX

$808.00K
ADVM annual capital expenditures is $808.00 thousand

CAPEX 1-year change

-93.16%
ADVM annual capital expenditures is down -93.16% year-on-year

Free Cash Flow

Free cash flow

-$91.71M
ADVM annual free cash flow is -$91.71 million

Free cash flow 1-year change

+23.52%
ADVM annual free cash flow is up +23.52% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ADVM annual gross profit margin value is unknown

Operating margin

-3444.19%
ADVM annual operating profit margin is -3444.19%

Net margin

-3254.58%
ADVM annual net profit margin is -3254.58%

ROA & ROE

ROA

-48.68%
ADVM annual return on assets is -48.68%

ROE

-88.43%
ADVM annual return on equity is -88.43%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADVM price to earnings ratio value is unknown

PE ratio Sector rank

-
ADVM price to earnings ratio is unknown

PB Ratio

PB ratio

0.50
ADVM price to book ratio is 0.50

PB ratio Sector rank

29.85%
ADVM price to book ratio is higher than 29.85% of companies in Healthcare sector

PS Ratio

PS ratio

71.87
ADVM price to sales ratio is 71.87

PS ratio Sector rank

93.85%
ADVM price to sales ratio is higher than 93.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$52.28M
ADVM enterprise value is $52.28 million

Enterprise value Sector rank

42.2%
ADVM enterprise value is higher than 42.2% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.53
ADVM EV/EBITDA is -0.53

EV/EBITDA Sector rank

50.65%
ADVM EV/EBITDA is higher than 50.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.13
ADVM annual current ratio is 4.13

Quick ratio

-
ADVM annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ADVM annual debt to equity ratio is 0.00

Interest coverage ratio

-
ADVM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ADVM piotroski f-score value is unknown

Altman Z-Score

-8.77
ADVM altman z-score is -8.77

Analyst ratings

Recent major analysts updates

Nov 19, 24 HC Wainwright & Co.
Buy
Nov 5, 24 RBC Capital
Sector Perform
Aug 14, 24 Truist Securities
Buy
Aug 13, 24 RBC Capital
Sector Perform
Aug 13, 24 HC Wainwright& Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Jul 18, 24 Chardan Capital
Buy
Jun 25, 24 Oppenheimer
Outperform
May 15, 24 Truist Securities
Buy
May 10, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ANL logo
Adlai Nortye American Depositary Shares (ANL)
IGMS logo
IGM Biosciences (IGMS)
ADAG logo
Adagene (ADAG)
TCRX logo
TScan Therapeutics (TCRX)
EPIX logo
ESSA Pharma (EPIX)
MLSS logo
Milestone Scientific (MLSS)
Alpha Cognition (ACOG)
CNTX logo
Context Therapeutics (CNTX)
ZYXI logo
Zynex (ZYXI)
  • What is the ticker symbol for Adverum Biotechnologies?
  • Does Adverum Biotechnologies pay dividends?
  • What sector is Adverum Biotechnologies in?
  • What industry is Adverum Biotechnologies in?
  • What country is Adverum Biotechnologies based in?
  • When did Adverum Biotechnologies go public?
  • Is Adverum Biotechnologies in the S&P 500?
  • Is Adverum Biotechnologies in the NASDAQ 100?
  • Is Adverum Biotechnologies in the Dow Jones?
  • When was Adverum Biotechnologies's last earnings report?
  • When does Adverum Biotechnologies report earnings?
  • Should I buy Adverum Biotechnologies stock now?

What is the ticker symbol for Adverum Biotechnologies?

The ticker symbol for Adverum Biotechnologies is NASDAQ:ADVM

Does Adverum Biotechnologies pay dividends?

No, Adverum Biotechnologies does not pay dividends

What sector is Adverum Biotechnologies in?

Adverum Biotechnologies is in the Healthcare sector

What industry is Adverum Biotechnologies in?

Adverum Biotechnologies is in the Biotechnology industry

What country is Adverum Biotechnologies based in?

Adverum Biotechnologies is headquartered in United States

When did Adverum Biotechnologies go public?

Adverum Biotechnologies's initial public offering (IPO) was on July 31, 2014

Is Adverum Biotechnologies in the S&P 500?

No, Adverum Biotechnologies is not included in the S&P 500 index

Is Adverum Biotechnologies in the NASDAQ 100?

No, Adverum Biotechnologies is not included in the NASDAQ 100 index

Is Adverum Biotechnologies in the Dow Jones?

No, Adverum Biotechnologies is not included in the Dow Jones index

When was Adverum Biotechnologies's last earnings report?

Adverum Biotechnologies's most recent earnings report was on Nov 4, 2024

When does Adverum Biotechnologies report earnings?

The next expected earnings date for Adverum Biotechnologies is Apr 15, 2025

Should I buy Adverum Biotechnologies stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page